Overview of the BioBank Japan Project: Study design and profile
2017 · Journal of Epidemiology · 747 citations
https://doi.org/10.1016/j.je.2016.12.005
T
Taisei Mushiroda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
317
Papers
10.4K
Citations
55
h-index
138
i10-index
Taisei Mushiroda is an academic researcher from RIKEN Center for Integrative Medical Sciences. The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & BRCA gene mutations in cancer & Drug-Induced Adverse Reactions. The author has an h-index of 55, co-authored 270 publications.
ORCID: 0000-0002-4139-8794Papers by this author
worksGenome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries
2021 · Nature Communications · 466 citations
https://doi.org/10.1038/s41467-020-20851-4
Clinical Pharmacogenetics Implementation Consortium Guideline for <i>HLA</i> Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
2018 · Clinical Pharmacology & Therapeutics · 291 citations
https://doi.org/10.1002/cpt.1004
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
2015 · Translational Psychiatry · 139 citations
https://doi.org/10.1038/tp.2015.47
Association of genetic polymorphisms in <i>SLCO1B3</i> and <i>ABCC2</i> with docetaxel‐induced leukopenia
2008 · Cancer Science · 134 citations
https://doi.org/10.1111/j.1349-7006.2008.00765.x
TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
2016 · Molecular Psychiatry · 116 citations
https://doi.org/10.1038/mp.2016.6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat